Study shows durable viral suppression of boosted REYATAZ in treatment-experienced HIV patients
2010-11-10
(Press-News.org) (GLASGOW, 9 November 2010) – Results from a European Observational Study, which included 1,294 antiretroviral (ARV)-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection (HIV10), demonstrated a low rate of discontinuation and sustained virologic suppression with REYATAZ® (atazanavir)/ritonavir-based regimens over a follow-up period of up to five years.1
The aim of this study was to investigate the long-term outcomes of REYATAZ/ritonavir-containing regimens in ARV-experienced patients in a real-life clinical setting. The primary endpoint of the cohort study was the proportion of patients who remained on treatment over time by baseline HIV-1 RNA level (< 500 copies/mL and >= 500 copies/mL). Secondary endpoints were reasons for discontinuation, time to virologic failure (defined as either two consecutive HIV-1 RNA >= 50 copies/mL or one HIV-1 RNA >= 50 copies/mL followed by discontinuation) and long-term safety profile.1
The results of the study revealed that 56% of patients with baseline viral suppression (< 500 copies/mL) (n= 722) and 53% of those with detectable viral load (>= 500 copies/mL) (n= 540) remained on treatment after 3 years with a median time to discontinuation of 4 versus 3.6 years, respectively. The overall discontinuation rate in the study was low (43%) with the reasons for discontinuation including adverse events (11%), withdrawn consent (6%) and lack of efficacy (6%). After three years on a REYATAZ/r-based regimen, 75% of patients with baseline HIV-1 RNA levels < 50 copies/mL remained suppressed and 51% of patients with baseline HIV-1 RNA levels >=50 copies/mL achieved and maintained virological suppression.1
Long-term safety outcomes from this real-life study were consistent with data observed in clinical trials: diarrhoea (4%), renal and urinary disorders (3%), nausea (< 1%) and jaundice (< 1%) were reported. Discontinuations due to hyperbilirubinemia were infrequent (< 1%) and no new or unexpected adverse events were observed.1
"Prior to this cohort study, less was known about long-term outcomes and the length of time on treatment in experienced patients after switching", said Professor Jan van Lunzen, M.D., Ph.D. of The University Medical Centre Hamburg-Eppendorf in Germany. "This cohort study shows in a real-life setting that a significant proportion of treatment-experienced patients stayed on an atazanavir/ritonavir-containing regimen for up to five years", he added.
Study Design
This real-life long-term cohort was a non-comparative, retrospective, observational study that collected data from three European databases (France – DatAids; Germany – KompNet; Sweden – InfCare). Clinical data from 1,294 ARV-experienced adult patients who started an atazanavir/ritonavir-based regimen between October 2004 and March 2007 were collected every six months (maximum follow-up of five years). Patients were predominately male (74%); their median age was 43 years and 75% had prior exposure to protease inhibitors (PIs).
INFORMATION:
About Bristol-Myers Squibb Company
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Contacts
Media:
Annie Simond, office: + 33 01 58 83 65 66
Joanna Ritter, office: + 33 01 58 83 65 09
Sources:
1 Jansen K, et al. Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced HIV Patients. Poster P031 accepted to HIV 10.
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-10
In a study of more than 9,600 adolescent and young adult women in the Baltimore area, researchers at the University of Maryland School of Medicine have found that fewer than 30 percent of those eligible to receive the human papillomavirus (HPV) vaccine to prevent cervical cancer actually chose to get it. And only about a third of those who began receiving the vaccine completed the three doses recommended for maximum protection.
The research, which was led by J. Kathleen Tracy, Ph.D., an assistant professor of epidemiology, will be presented on Nov. 9, 2010, at a cancer ...
2010-11-10
Washington, D.C. (November 9, 2010) -- Current medical techniques for monitoring the heart rate and other vital signs use electrodes attached to the body, which are impractical for patients who want to move around. Plasma physicist Atsushi Mase, a scientist at Kyushu University in Japan, and colleague Daisuke Nagae have developed a new technique to disconnect people from their electrodes by using microwaves.
The work, which could lead to the development of non-invasive, real-time stress sensing in a variety of environments, is described in a recent issue of the journal ...
2010-11-10
Washington, D.C. (November 9, 2010) -- A switch to wind energy will help reduce greenhouse gas emissions -- and reduce the global warming they cause. But there's a catch, says climate researcher Diandong Ren, a research scientist at the University of Texas at Austin in a paper appear in the AIP's Journal of Renewable and Sustainable Energy: rising temperatures decrease wind speeds, making for less power bang for the wind turbine buck.
The prevailing winds in the "free" atmosphere about 1,000 meters above the ground are maintained by a temperature gradient that decreases ...
2010-11-10
Washington, D.C. (November 9, 2010) -- Microscopically porous polymer membranes have numerous applications in microfluidics, where they can act as filters, masks for surface patterning, and even as components in 3D devices in which the perforations in stacked membranes are aligned to form networks of channels for the flow of fluids.
In the AIP journal Biomicrofluidics, Hongkai Wu, a chemist at Hong Kong University of Science and Technology, and his colleagues describe a simple new method using just one photolithographic step to fabricate free-standing polymer membranes ...
2010-11-10
Washington, D.C. (November 9, 2010) -- Researchers at the University of Maryland have proposed a scheme for detecting a concealed source of radioactive material without searching containers one by one. Detection of radioactive material concealed in shipping containers is important in the early prevention of "dirty" bomb construction. The concept, described in the Journal of Applied Physics, is based on the gamma-ray emission from the radioactive material that would pass through the shipping container walls and ionize the surrounding air.
The facilitated breakdown of ...
2010-11-10
Washington, D.C. (November 9, 2010) -- Walk into nearly any science museum worth its salt and you're likely to see a Foucault pendulum, a simple but impressive device for observing the Earth's rotation. Such pendulums have been around for more than 150 years, and little about how they work remains a mystery today.
The only problem, according to Argentinean researcher Horacio Salva, is that the devices are generally large and unwieldy, making them impractical to install in places where space is at a premium. This limitation was something he and his colleagues at the Centro ...
2010-11-10
At the current pace of research and development, global oil will run
out 90 years before replacement technologies are ready, says a new
University of California, Davis, study based on stock market
expectations.
The forecast was published online Monday (Nov. 8) in the journal
Environmental Science & Technology. It is based on the theory that
long-term investors are good predictors of whether and when new
energy technologies will become commonplace.
"Our results suggest it will take a long time before renewable
replacement fuels can be self-sustaining, at least ...
2010-11-10
A team of international researchers led by ancient DNA experts from the University of Adelaide has resolved the longstanding issue of the origins of the people who introduced farming to Europe some 8000 years ago.
A detailed genetic study of one of the first farming communities in Europe, from central Germany, reveals marked similarities with populations living in the Ancient Near East (modern-day Turkey, Iraq and other countries) rather than those from Europe.
Project leader Professor Alan Cooper, Director of the Australian Centre for Ancient DNA (ACAD) at the University ...
2010-11-10
Astronomers at The University of Warwick and the University of Sheffield have helped discover an unusual star system which looks like, and may even once have behaved like, a game of snooker.
The University of Warwick and Sheffield astronomers played a key role in an international team that used two decades of observations from many telescopes around the world. The UK astronomers helped discover this "snooker like" star system through observations and analysis of data from an astronomical camera known as ULTRACAM designed by the British researchers on the team.
They ...
2010-11-10
Kyoto, Japan -- As if borrowing from a scene in a science fiction movie, researchers at Kyoto University have successfully developed a kind of tractor beam that can be used to manipulate the network of the molecules. In a paper soon to be published in Physical Review Letters, the team has demonstrated a technique using terahertz pulses that could have broad applications in the chemical and pharmaceutical industries.
Terahertz waves, an area of specialty for the Koichiro Tanaka lab at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), exist in ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study shows durable viral suppression of boosted REYATAZ in treatment-experienced HIV patients
